Get the Stockscreener App
40.28
3.07%
1.20
After Hours:
40.48
0.20
+0.50%
Cg Oncology Inc stock is traded at $40.28, with a volume of 752.06K.
It is up +3.07% in the last 24 hours and up +50.19% over the past month.
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.
See More
Previous Close:
$39.08
Open:
$39.1
24h Volume:
752.06K
Relative Volume:
0.83
Market Cap:
$3.07B
Revenue:
-
Net Income/Loss:
$-64.16M
P/E Ratio:
-31.71
EPS:
-1.2702
Net Cash Flow:
$-69.06M
1W Performance:
+9.75%
1M Performance:
+50.19%
6M Performance:
+64.48%
1Y Performance:
+6.76%
1-Day Range:
$38.63
$40.53
1-Week Range:
$35.64
$40.53
52-Week Range:
$14.80
$40.53
Cg Oncology Inc Stock (CGON) Company Profile
Name
Cg Oncology Inc
Sector
Industry
Phone
(949) 419-6203
Address
400 SPECTRUM CENTER DRIVE, IRVINE
Compare CGON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
40.28 | 2.98B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.64 | 101.35B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.00 | 58.66B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
562.27 | 59.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
737.56 | 44.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
340.70 | 36.56B | 3.81B | -644.79M | -669.77M | -6.24 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-25 | Initiated | Piper Sandler | Overweight |
| Jul-10-25 | Resumed | Goldman | Buy |
| May-02-25 | Initiated | JP Morgan | Overweight |
| Apr-16-25 | Initiated | Scotiabank | Sector Perform |
| Jan-07-25 | Initiated | TD Cowen | Buy |
| Oct-24-24 | Initiated | UBS | Buy |
| Sep-23-24 | Initiated | RBC Capital Mkts | Outperform |
| Aug-28-24 | Initiated | ROTH MKM | Buy |
| Jun-28-24 | Initiated | BofA Securities | Buy |
| Feb-20-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-20-24 | Initiated | Goldman | Neutral |
| Feb-20-24 | Initiated | Morgan Stanley | Overweight |
| Feb-14-24 | Initiated | H.C. Wainwright | Buy |
View All
Cg Oncology Inc Stock (CGON) Latest News
Cg Oncology stock hits 52-week high at 40.49 USD - Investing.com
Best data tools to analyze CG Oncology Inc. stockShare Buyback & Low Drawdown Momentum Ideas - newser.com
Ranking CG Oncology Inc. among high performing stocks via toolsMarket Trend Report & Reliable Price Breakout Alerts - newser.com
How CG Oncology Inc. stock reacts to bond yieldsWeekly Market Summary & Low Drawdown Investment Ideas - newser.com
Published on: 2025-09-30 01:30:52 - earlytimes.in
What’s next for CG Oncology Inc. stock priceIPO Watch & Risk Managed Investment Strategies - newser.com
What analysts say about CG Oncology Inc stockRetail Trading Trends & Double Digit Trading Ideas - earlytimes.in
Applying Elliott Wave Theory to CG Oncology Inc.Weekly Investment Summary & Free High Accuracy Swing Entry Alerts - newser.com
CG Oncology Inc Stock Analysis and ForecastSector Leadership Analysis & Free Unstoppable Trading Performance - Early Times
Is CG Oncology Inc a good long term investmentHigh Yield Income Stocks & Start Building Capital with Zero Risk - Early Times
Midday Stock Roundup: Clean Energy Fuels Corp. Up Nearly 6% - Orange County Business Journal
How analysts rate CG Oncology Inc. stock todayWeekly Earnings Recap & Safe Entry Point Identification - newser.com
JPMorgan Chase & Co. Issues Positive Forecast for CG Oncology (NASDAQ:CGON) Stock Price - MarketBeat
CG Oncology (CGON): Assessing Valuation After New Clinical Milestones and Regulatory Pipeline Updates - Sahm
Mulay James sells CG Oncology (CGON) stock worth $884k - Investing.com India
Can you recover from losses in CG Oncology Inc.Quarterly Earnings Report & Expert Approved Momentum Trade Ideas - newser.com
Mulay James sells CG Oncology (CGON) stock worth $884k By Investing.com - Investing.com Australia
Insider Selling: CG Oncology (NASDAQ:CGON) Director Sells 3,574 Shares of Stock - MarketBeat
James Mulay Sells 19,112 Shares of CG Oncology (NASDAQ:CGON) Stock - MarketBeat
CG Oncology Insider Sold Shares Worth $884,909, According to a Recent SEC Filing - MarketScreener
How to monitor CG Oncology Inc. with trend dashboardsJuly 2025 Trade Ideas & Verified Entry Point Detection - newser.com
CG Oncology (NASDAQ:CGON) Stock Price Expected to Rise, Morgan Stanley Analyst Says - MarketBeat
CG Oncology (CGON) PT Raised to $79 by Morgan Stanley on Strong Clinical Pipeline for Bladder Cancer Treatment - Insider Monkey
CG Oncology (NASDAQ:CGON) Shares Down 5.1%Here's Why - MarketBeat
Combining machine learning predictions for CG Oncology Inc.2025 Breakouts & Breakdowns & Low Risk High Win Rate Picks - newser.com
CG Oncology (NASDAQ:CGON) Trading 6% Higher on Insider Buying Activity - MarketBeat
Chart Watch: Can CG Oncology Inc. deliver consistent EPS growthM&A Rumor & Entry Point Strategy Guides - خودرو بانک
Leonard E. Post Sells 1,000 Shares of CG Oncology (NASDAQ:CGON) Stock - MarketBeat
Brian Guan-Chyun Liu Acquires 1,515,151 Shares of CG Oncology (NASDAQ:CGON) Stock - MarketBeat
CG Oncology (NASDAQ:CGON) Shares Gap Up on Insider Buying Activity - MarketBeat
CG Oncology Inc. stock prediction for this weekDip Buying & Advanced Swing Trade Entry Alerts - newser.com
Aug Technicals: Can CG Oncology Inc. deliver alpha2025 Sector Review & Weekly High Return Opportunities - خودرو بانک
Strength Seen in Intellia Therapeutics (NTLA): Can Its 29.8% Jump Turn into More Strength? - Yahoo Finance
Market Wrap: How cyclical is CG Oncology Inc.’s revenue streamJuly 2025 Gainers & AI Driven Stock Movement Reports - خودرو بانک
Aug Swings: Is CG Oncology Inc stock risky to hold nowQuarterly Performance Summary & Consistent Profit Trade Alerts - خودرو بانک
Piper Sandler initiates coverage of oncology companies - MSN
Wesbanco Bank Inc. Takes Position in CG Oncology, Inc. $CGON - MarketBeat
CG Oncology, Inc. (CGON) Moves 5.5% Higher: Will This Strength Last? - Yahoo Finance
Aug Retail: How does CG Oncology Inc. score in quality rankingsProfit Target & Low Risk High Reward Trade Ideas - خودرو بانک
FY2026 EPS Estimates for CG Oncology Cut by Lifesci Capital - MarketBeat
Street Watch: What is the target price for CG Oncology Inc stockJuly 2025 Snapshot & Real-Time Volume Trigger Notifications - خودرو بانک
Morgan Stanley Issues Positive Forecast for CG Oncology (NASDAQ:CGON) Stock Price - Defense World
Analysts Are Bullish on Top NA Stocks: CG Oncology, Inc. (CGON), Rubrik, Inc. Class A (RBRK) - The Globe and Mail
CG Oncology announces mixed shelf offering - MSN
Woodline Partners LP Grows Holdings in CG Oncology, Inc. $CGON - MarketBeat
Cg Oncology Inc Stock (CGON) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.36%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):